ASXL-Related Disorders Natural History Study

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT03303716
Status
Recruiting
Apply to this trial

Conditions

  • ASXL1 Gene Mutation
  • ASXL2 Gene Mutation
  • ASXL3 Gene Mutation
  • Bainbridge-Ropers Syndrome
  • Bohring-Opitz Syndrome
  • Shashi-Pena Syndrome

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).

Key Dates

Start date
Sep 20, 2017
Status verified
Dec 2025
Primary completion
Sep 30, 2037
Completion
Sep 30, 2037

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Natural history, treatment and management strategies of ASXL-related disorders [ Time Frame: 20 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, Los AngelesLos AngelesCalifornia90095
Bianca Russell, MD
[email protected]
310-206-6581

Find similar trials in Los Angeles, CA

By research site
University of California, Los Angeles· Los Angeles, CA

Related Studies